Status:
SUSPENDED
Transcranial Magnetic Brain Stimulation to Reduce Cannabis Use in Heavy Cannabis Users
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cannabis
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The growing legalization of cannabis across the U.S. is associated with increases in cannabis use, and accordingly, an increase in the number of individuals with cannabis use problems, including canna...
Detailed Description
This study is pending transfer to Duke University.
Eligibility Criteria
Inclusion
- Males/non-pregnant females, 18-60 years old
- Current cannabis user
- Able to perform all study procedures
Exclusion
- Use of other illicit drugs
- If medical history, physical and psychiatric examination, or laboratory tests performed during the screening process reveal any significant illness that the study physician deems contraindicated for study participation
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2029
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT05401929
Start Date
June 1 2022
End Date
July 1 2029
Last Update
October 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032